Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures

…, DW Blom, EA Lyle, DAMC van de Vijver… - Clinical Infectious …, 2006 - academic.oup.com
Background . The role of environmental contamination in nosocomial cross-transmission of
antibiotic-resistant bacteria has been unresolved. Using vancomycin-resistant enterococci (…

[HTML][HTML] Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

JJA van Kampen, DAMC van de Vijver… - Nature …, 2021 - nature.com
Key questions in COVID-19 are the duration and determinants of infectious virus shedding.
Here, we report that infectious virus shedding is detected by virus cultures in 23 of the 129 …

Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants

JJA van Kampen, DAMC van de Vijver, PLA Fraaij… - MedRxiv, 2020 - medrxiv.org
Background Long-term shedding of viral RNA in COVID-19 prevents timely discharge from
the hospital or de-escalation of infection prevention and control practices. Key questions are …

[HTML][HTML] Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and …

…, KK Tee, HHM Truong, DAMC van de Vijver… - PLoS …, 2015 - journals.plos.org
Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug
resistance (TDR) are essential for informing first-line antiretroviral (ARV) therapy guidelines …

Transmission of drug-resistant HIV-1 is stabilizing in Europe

…, AMJ Wensing, DAMC van de Vijver… - The Journal of …, 2009 - academic.oup.com
The SPREAD Programme investigated prospectively the time trend from September 2002
through December 2005 of transmitted drug resistance (TDR) among 2793 patients in 20 …

[HTML][HTML] Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 …

…, JA Salomon, DAMC van de Vijver… - The Lancet Global …, 2014 - thelancet.com
Background New WHO guidelines recommend initiation of antiretroviral therapy for HIV-positive
adults with CD4 counts of 500 cells per μL or less, a higher threshold than was …

Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

…, F Garcia, D Struck, DAMC Van de Vijver… - Clinical infectious …, 2016 - academic.oup.com
Background. Numerous studies have shown that baseline drug resistance patterns may
influence the outcome of antiretroviral therapy. Therefore, guidelines recommend drug …

[HTML][HTML] HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

…, J Vercauteren, K Theys, DAMC Van de Vijver… - Retrovirology, 2013 - Springer
Background Understanding HIV-1 subtype distribution and epidemiology can assist preventive
measures and clinical decisions. Sequence variation may affect antiviral drug resistance …

Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis

M van Velzen, DAMC van de Vijver… - The Journal of …, 2013 - academic.oup.com
Purpose. Long-term acyclovir (ACV) prophylaxis, recommended to prevent recurrent herpes
simplex virus type 1 (HSV-1) ocular disorders, may pose a risk for ACV-refractory disease …

Declining hepatitis C virus (HCV) incidence in Dutch human immunodeficiency virus-positive men who have sex with men after unrestricted access to HCV therapy

…, S Popping, DAMC Van de Vijver… - Clinical Infectious …, 2018 - academic.oup.com
Background Direct-acting antivirals (DAAa) cure hepatitis C virus (HCV) infections in 95% of
infected patients. Modeling studies predict that universal HCV treatment will lead to a …